Kuickresearch::Industry News

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

Personalised Cancer Vaccine in Clinical Trail Phase

Release Date: 18 September 2019

In 2014, six melanoma patients received infusions of anticancer vaccine composed of their dendritic cells of the patient’s own body. The experiment was performed at Washington University School of Medicine in St. Louis. Frist of al...

Read More


Oral Antibiotics Increase the Risk of Colon Cancer

Release Date: 18 September 2019

The researchers recently founds that multiple consumption of oral antibiotics may lead to development of colon cancer. The commonly used antibiotics such as penicillin and cephalosporin may results in the colon cancer. The antibiotics, w...

Read More


ALLO 715 - An Allogeneic CAR T Cell Therapy Moves Into Clinical Phase

Release Date: 17 September 2019

Allogene therapeutics is working on a new CAR T cell therapy named ALLO 715 for patients with multiple myeloma. Recently, the first clinical trial report of ALLO 715 is about to launch. US FDA also approves the new drug application of AL...

Read More


ALLO 715 - An Allogeneic CAR T Cell Therapy Moves Into Clinical Phase

Release Date: 17 September 2019

Allogene therapeutics is working on a new CAR T cell therapy named ALLO 715 for patients with multiple myeloma. Recently, the first clinical trial report of ALLO 715 is about to launch. US FDA also approves the new drug application of AL...

Read More


NEO Personalised Vaccine Shows Promising Action Against Advanced Cancers

Release Date: 17 September 2019

NEO-PV-01 is a new product of Neon Therapeutics, which is active against cancer. New results released by Neon Therapeutics have shown promising, early results for their personalized neoantigen vaccine in 3 different types of advance...

Read More


T-Cell Cryopreservation - Future of Cancer Management

Release Date: 17 September 2019

A new concept is identified for treating the cancer, which is known as T-Cell Cryopreservation. Recently, Cell Vault announced to launch world’s first T-Cell Cryopreservation bank in US. Cell Vault wants to make T-cell collection a...

Read More


Multiple Myeloma Treatment by Synergistic Action of CAR-T Cells

Release Date: 16 September 2019

In the patients of multiple myeloma, a synergistic action of a combination of humanized anti-CD19 and anti-B-cell maturation antigen chimeric antigen receptor T-cells has observed in a phase II clinical trial published in Lancet Haematol...

Read More


CAR-T Cell Therapy - Major Step Towards New Therapy Approval

Release Date: 16 September 2019

A new CAR-T cell therapy derived from induced pluripotent stem cells (iPSCs) has been transferred to Takeda from the Centre of iPS Re...

Read More


Global Orphan Therapy Clinical Pipeline Market Report Published by KuicK Research

Release Date: 20 April 2017

“Global Orphan Disease Clinical Pipeline Insight 2022” reports by KuicK Research gives comprehensive insight on various clinical and non-clinical aspects associated with ongoing clinical development ...

Read More


Global Oncolytic Virus Therapy Market and Pipeline Report Published by KuicK Research

Release Date: 20 April 2017

“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercial...

Read More


EU grants orphan drug status to Strekin's STR001 for Sudden Sensorineural Hearing Loss

Release Date: 19 April 2017

European Medicine Agency (EMA) has granted orohan drug designation to Sterkin AG, a clinical stage biopharmaceutical company’s development candidate STR001 for the treatment of patients with Sudden Sensorineural Hearing Loss.

Read More


Global Cancer Immunotherapy Market Report 2022 Published by Kuick Research

Release Date: 18 April 2017

For Report Sample Contact: neeraj@kuick Research
 
"Global Cancer Immunotherapy Market Outlook 2022" Report Highlights:

 ...

Read More


Personalized Cancer Vaccines Market Report Published By KuicK Research

Release Date: 18 April 2017

The report “Personalized Cancer Vaccines Market and Clinical Innovation Outlook 2022” is an inclusive report which covers the current and future opportunities for the personalized cancer vaccines and its varied inclinations i...

Read More


NantCell receives FDA orphan drug status for Ganitumab Monoclonal Antibody Therapy in Ewing Sarcoma

Release Date: 18 April 2017

NantCell, Inc., part of the NantWorks ecosystem of companies, has been granted orphan drug designation from US Food and Drug Administration (FDA) for the company’s Ganitumab, Insulin Growth Factor-1R (IGF-1R) Monoclonal Antibody Th...

Read More


Global Cancer Nanomedicine Market Report Published by KuicK Research

Release Date: 17 April 2017

Global Cancer Nanomedicine Market Outlook 2022  Report Highlights:

 

andbull; Overview and Mechanism of Action of Nanomedicine

Read More


1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

Need custom market research solution? We can help you with that too.